Skip to main content
PMC home page
American Journal of Public Health logoLink to American Journal of Public Health
. 1990 Oct;80(10):1266–1268. doi: 10.2105/ajph.80.10.1266

Are women using postmenopausal estrogens? A community survey.

R B Harris 1, A Laws 1, V M Reddy 1, A King 1, W L Haskell 1
PMCID: PMC1404801  PMID: 2400044

Abstract

Self-reported estrogen and progestin use in a California community was determined in 1986-87 from a telephone survey of postmenopausal women (n = 954) ages 50-65 years. Current use of hormones was reported by 32 percent; 26 percent took estrogens alone while 6 percent used estrogen + progestin. Comparisons pointed to significant social network and medical care utilization differences. Women who used estrogen therapy were younger, thinner, lived in smaller household units, and were less likely to be widowed.

Full text

PDF
1266

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Barrett-Connor E., Brown W. V., Turner J., Austin M., Criqui M. H. Heart disease risk factors and hormone use in postmenopausal women. JAMA. 1979 May 18;241(20):2167–2169. [PubMed] [Google Scholar]
  2. Barrett-Connor E. Postmenopausal estrogens--current prescribing patterns of San Diego gynecologists. West J Med. 1986 May;144(5):620–621. [PMC free article] [PubMed] [Google Scholar]
  3. Barrett-Connor E., Wingard D. L., Criqui M. H. Postmenopausal estrogen use and heart disease risk factors in the 1980s. Rancho Bernardo, Calif, revisited. JAMA. 1989 Apr 14;261(14):2095–2100. [PubMed] [Google Scholar]
  4. Bergkvist L., Adami H. O., Persson I., Hoover R., Schairer C. The risk of breast cancer after estrogen and estrogen-progestin replacement. N Engl J Med. 1989 Aug 3;321(5):293–297. doi: 10.1056/NEJM198908033210505. [DOI] [PubMed] [Google Scholar]
  5. Bradley D. D., Wingerd J., Petitti D. B., Krauss R. M., Ramcharan S. Serum high-density-lipoprotein cholesterol in women using oral contraceptives, estrogens and progestins. N Engl J Med. 1978 Jul 6;299(1):17–20. doi: 10.1056/NEJM197807062990104. [DOI] [PubMed] [Google Scholar]
  6. Bush T. L., Barrett-Connor E., Cowan L. D., Criqui M. H., Wallace R. B., Suchindran C. M., Tyroler H. A., Rifkind B. M. Cardiovascular mortality and noncontraceptive use of estrogen in women: results from the Lipid Research Clinics Program Follow-up Study. Circulation. 1987 Jun;75(6):1102–1109. doi: 10.1161/01.cir.75.6.1102. [DOI] [PubMed] [Google Scholar]
  7. Cafferata G. L. Marital status, living arrangements, and the use of health services by elderly persons. J Gerontol. 1987 Nov;42(6):613–618. doi: 10.1093/geronj/42.6.613. [DOI] [PubMed] [Google Scholar]
  8. Gambrell R. D., Jr The menopause: benefits and risks of estrogen-progestogen replacement therapy. Fertil Steril. 1982 Apr;37(4):457–474. doi: 10.1016/s0015-0282(16)46149-2. [DOI] [PubMed] [Google Scholar]
  9. Hammond C. B., Jelovsek F. R., Lee K. L., Creasman W. T., Parker R. T. Effects of long-term estrogen replacement therapy. II. Neoplasia. Am J Obstet Gynecol. 1979 Mar 1;133(5):537–547. doi: 10.1016/0002-9378(79)90289-8. [DOI] [PubMed] [Google Scholar]
  10. Hemminki E., Kennedy D. L., Baum C., McKinlay S. M. Prescribing of noncontraceptive estrogens and progestins in the United States, 1974-86. Am J Public Health. 1988 Nov;78(11):1479–1481. doi: 10.2105/ajph.78.11.1479. [DOI] [PMC free article] [PubMed] [Google Scholar]
  11. Jensen J., Nilas L., Christiansen C. Cyclic changes in serum cholesterol and lipoproteins following different doses of combined postmenopausal hormone replacement therapy. Br J Obstet Gynaecol. 1986 Jun;93(6):613–618. doi: 10.1111/j.1471-0528.1986.tb08035.x. [DOI] [PubMed] [Google Scholar]
  12. Kennedy D. L., Baum C., Forbes M. B. Noncontraceptive estrogens and progestins: use patterns over time. Obstet Gynecol. 1985 Mar;65(3):441–446. [PubMed] [Google Scholar]
  13. MacDonald P. C. Estrogen plus progestin in postmenopausal women--act II. N Engl J Med. 1986 Oct 9;315(15):959–961. doi: 10.1056/NEJM198610093151510. [DOI] [PubMed] [Google Scholar]
  14. Markush R. E., Turner S. L. Epidemiology of exogenous estrogens. HSMHA Health Rep. 1971 Jan;86(1):74–86. [PMC free article] [PubMed] [Google Scholar]
  15. Marrett L. D., Meigs J. W., Flannery J. T. Trends in the incidence of cancer of the corpus uteri in Connecticut, 1964-1979, in relation to consumption of exogenous estrogens. Am J Epidemiol. 1982 Jul;116(1):57–67. doi: 10.1093/oxfordjournals.aje.a113402. [DOI] [PubMed] [Google Scholar]
  16. Pasley B. H., Standfast S. J., Katz S. H. Prescribing estrogen during menopause: physician survey of practices in 1974 and 1981. Public Health Rep. 1984 Jul-Aug;99(4):424–429. [PMC free article] [PubMed] [Google Scholar]
  17. Pfeffer R. I., Whipple G. H., Kurosaki T. T., Chapman J. M. Coronary risk and estrogen use in postmenopausal women. Am J Epidemiol. 1978 Jun;107(6):479–497. doi: 10.1093/oxfordjournals.aje.a112567. [DOI] [PubMed] [Google Scholar]
  18. Quigley M. M., Hammond C. B. Estrogen-replacement therapy--help or hazard? N Engl J Med. 1979 Sep 20;301(12):646–648. doi: 10.1056/NEJM197909203011206. [DOI] [PubMed] [Google Scholar]
  19. Rosenberg L., Armstrong B., Jick H. Myocardial infarction and estrogen therapy in post-menopausal women. N Engl J Med. 1976 Jun 3;294(23):1256–1259. doi: 10.1056/NEJM197606032942302. [DOI] [PubMed] [Google Scholar]
  20. Ross R. K., Paganini-Hill A., Mack T. M., Arthur M., Henderson B. E. Menopausal oestrogen therapy and protection from death from ischaemic heart disease. Lancet. 1981 Apr 18;1(8225):858–860. doi: 10.1016/s0140-6736(81)92138-3. [DOI] [PubMed] [Google Scholar]
  21. Ross R. K., Paganini-Hill A., Roy S., Chao A., Henderson B. E. Past and present preferred prescribing practices of hormone replacement therapy among Los Angeles gynecologists: possible implications for public health. Am J Public Health. 1988 May;78(5):516–519. doi: 10.2105/ajph.78.5.516. [DOI] [PMC free article] [PubMed] [Google Scholar]
  22. Shoemaker E. S., Forney J. P., MacDonald P. C. Estrogen treatment of postmenopausal women. Benefits and risks. JAMA. 1977 Oct 3;238(14):1524–1530. [PubMed] [Google Scholar]
  23. Stampfer M. J., Willett W. C., Colditz G. A., Rosner B., Speizer F. E., Hennekens C. H. A prospective study of postmenopausal estrogen therapy and coronary heart disease. N Engl J Med. 1985 Oct 24;313(17):1044–1049. doi: 10.1056/NEJM198510243131703. [DOI] [PubMed] [Google Scholar]
  24. Sullivan J. M., Vander Zwaag R., Lemp G. F., Hughes J. P., Maddock V., Kroetz F. W., Ramanathan K. B., Mirvis D. M. Postmenopausal estrogen use and coronary atherosclerosis. Ann Intern Med. 1988 Mar;108(3):358–363. doi: 10.7326/0003-4819-108-3-358. [DOI] [PubMed] [Google Scholar]
  25. Tikkanen M. J., Nikkila E. A., Vartiainen E. Natural oestrogen as an effective treatment for type-II hyperlipoproteinaemia in postmenopausal women. Lancet. 1978 Sep 2;2(8088):490–491. doi: 10.1016/s0140-6736(78)92216-x. [DOI] [PubMed] [Google Scholar]
  26. Wahl P., Walden C., Knopp R., Hoover J., Wallace R., Heiss G., Rifkind B. Effect of estrogen/progestin potency on lipid/lipoprotein cholesterol. N Engl J Med. 1983 Apr 14;308(15):862–867. doi: 10.1056/NEJM198304143081502. [DOI] [PubMed] [Google Scholar]
  27. Weiss N. S., Szekely D. R., English D. R., Schweid A. I. Endometrial cancer in relation to patterns of menopausal estrogen use. JAMA. 1979 Jul 20;242(3):261–264. [PubMed] [Google Scholar]
  28. Wilson P. W., Garrison R. J., Castelli W. P. Postmenopausal estrogen use, cigarette smoking, and cardiovascular morbidity in women over 50. The Framingham Study. N Engl J Med. 1985 Oct 24;313(17):1038–1043. doi: 10.1056/NEJM198510243131702. [DOI] [PubMed] [Google Scholar]

Articles from American Journal of Public Health are provided here courtesy of American Public Health Association

RESOURCES